Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report

BACKGROUND: Currently available treatments have only been partly successful in patients with severe hypertriglyceridemia, including those with high serum triglycerides above 1,000 mg/dL (11.3 mmol/L), who often suffer from acute pancreatitis. Pemafibrate is a novel selective peroxisome proliferator-...

Descripción completa

Detalles Bibliográficos
Autores principales: Iitake, Chie, Masuda, Daisaku, Koseki, Masahiro, Yamashita, Shizuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694943/
https://www.ncbi.nlm.nih.gov/pubmed/33246467
http://dx.doi.org/10.1186/s12933-020-01172-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694943/
https://www.ncbi.nlm.nih.gov/pubmed/33246467
http://dx.doi.org/10.1186/s12933-020-01172-8

Ejemplares similares